GLUT2 accumulation in enterocyte apical and intracellular membranes: A study in morbidly obese human subjects and ob/ob and high fat-fed mice

Diabetes

Volumn 60, Issue 10, 2011, Pages 2598-2607

  Ait Omar, Amal ^a   Monteiro Sepulveda, Milena ^a   Poitou, Christine ^a,b,c   Le Gall, Maude ^a   Cotillard, Aurélie ^a   Gilet, Jules ^a   Garbin, Kevin ^a   Houllier, Anne ^a   Château, Danièle ^a   Lacombe, Amélie ^d   Veyrie, Nicolas ^a,e   Hugol, Danielle ^e   Tordjman, Joan ^a   Magnan, Christophe ^d   Serradas, Patricia ^a   Clément, Karine ^a,b,c   Leturque, Armelle ^a   Brot Laroche, Edith ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CENTRE MAURICE HALBWACHS   (France)

^d CNRS   (France)

^e HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY ENDOSOME ANTIGEN 1; GLUCOSE TRANSPORTER 2; METFORMIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CONTROLLED STUDY; FEMALE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTESTINE CELL; INTRACELLULAR MEMBRANE; LIPID DIET; LOW CARBOHYDRATE DIET; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ADULT; ANIMALS; CELL MEMBRANE; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DIETARY FATS; ENTEROCYTES; GLUCOSE TRANSPORTER TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MICE; MICE, INBRED C57BL; MICE, OBESE; MIDDLE AGED; OBESITY, MORBID; YOUNG ADULT;

EID: 80053407853     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-1740     Document Type: Article

References (43)

1. Drozdowski L, Thomson AB. Intestinal hormones and growth factors: effects on the small intestine. World J Gastroenterol 2009;15:385-406
2. Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med 2007;261:32-43 (Pubitemid 46046470)
3. Chaikomin R, Doran S, Jones KL, et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects. Am J Physiol Endocrinol Metab 2005;289:E504-E507 (Pubitemid 41192706)
4. Raybould HE. Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J Physiol Biochem 2008;64:349-356
5. Burant CF, Takeda J, Brot-Laroche E, Bell GI, Davidson NO. Fructose transporter in human spermatozoa and small intestine is GLUT5. J Biol Chem 1992;267:14523-14526
6. Thorens B. Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 1996;270:G541-G553
7. Cheeseman CI, Maenz DD. Rapid regulation of D-glucose transport in basolateral membrane of rat jejunum. Am J Physiol 1989;256:G878-G883
8. Cheeseman C. GLUT7: a new intestinal facilitated hexose transporter. Am J Physiol Endocrinol Metab 2008;295:E238-E241
9. Kellett GL, Helliwell PA. The diffusive component of intestinal glucose absorption is mediated by the glucose-induced recruitment of GLUT2 to the brush-border membrane. Biochem J 2000;350:155-162
10. Gouyon F, Caillaud L, Carriere V, et al. Simple-sugar meals target GLUT2 at enterocyte apical membranes to improve sugar absorption: a study in GLUT2-null mice. J Physiol 2003;552:823-832 (Pubitemid 37428423)
11. Habold C, Foltzer-Jourdainne C, Le Maho Y, Lignot JH, Oudart H. Intestinal gluconeogenesis and glucose transport according to body fuel availability in rats. J Physiol 2005;566:575-586 (Pubitemid 41030561)
12. Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008;28:35-54
13. Kellett GL, Brot-Laroche E. Apical GLUT2: a major pathway of intestinal sugar absorption. Diabetes 2005;54:3056-3062 (Pubitemid 41401109)
14. Tobin V, Le Gall M, Fioramonti X, et al. Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice. Diabetes 2008;57:555-562
15. Kwon O, Eck P, Chen S, et al. Inhibition of the intestinal glucose transporter GLUT2 by flavonoids. FASEB J 2007;21:366-377 (Pubitemid 46213484)
16. Burant CF, Flink S, DePaoli AM, et al. Small intestine hexose transport in experimental diabetes: increased transporter mRNA and protein expression in enterocytes. J Clin Invest 1994;93:578-585
17. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000;106: 473-481 (Pubitemid 30666380)
18. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846 (Pubitemid 46024990)
19. Saberi M, Woods NB, De Luca C, et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 2009;10:419-429
20. Bailey CJ. Insulin resistance and antidiabetic drugs. Biochem Pharmacol 1999;58:1511-1520 (Pubitemid 29467335)
21. Dyer J, Wood IS, Palejwala A, Ellis A, Shirazi-Beechey SP. Expression of monosaccharide transporters in intestine of diabetic humans. Am J Physiol Gastrointest Liver Physiol 2002;282:G241-G248 (Pubitemid 34651680)
22. Bailey CJ, Wilcock C, Day C. Effect of metformin on glucose metabolism in the splanchnic bed. Br J Pharmacol 1992;105:1009-1013
23. Pénicaud L, Hitier Y, Ferré P, Girard J. Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J 1989;262:881-885 (Pubitemid 19225163)
24. Lenzen S, Lortz S, Tiedge M. Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats. Biochem Pharmacol 1996;51:893-896 (Pubitemid 26109489)
25. Ikeda T, Iwata K, Murakami H. Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol 2000; 59:887-890 (Pubitemid 30081713)
26. Walker J, Jijon HB, Diaz H, Salehi P, Churchill T, Madsen KL. 5-Aminoimidazole- 4-carboxamide riboside (AICAR) enhances GLUT2-dependent jejunal glucose transport: a possible role for AMPK. Biochem J 2005;385:485-491 (Pubitemid 40173969)
27. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351:2683-2693 (Pubitemid 39665322)
28. Burcelin R, Crivelli V, Dacosta A, Roy-Tirelli A, Thorens B. Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am J Physiol Endocrinol Metab 2002;282:E834-E842 (Pubitemid 34654745)
29. Lee S, Muniyappa R, Yan X, et al. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am J Physiol Endocrinol Metab 2008;294:E261-E270 (Pubitemid 351231452)
30. Affleck JA, Helliwell PA, Kellett GL. Immunocytochemical detection of GLUT2 at the rat intestinal brush-border membrane. J Histochem Cytochem 2003;51:1567-1574 (Pubitemid 37444544)
31. Brot-Laroche E, Dao MT, Alcalde AI, Delhomme B, Triadou N, Alvarado F. Independent modulation by food supply of two distinct sodium-activated D-glucose transport systems in the guinea pig jejunal brush-border membrane. Proc Natl Acad Sci U S A 1988;85:6370-6373
32. Corpe CP, Basaleh MM, Affleck J, Gould G, Jess TJ, Kellett GL. The regulation of GLUT5 and GLUT2 activity in the adaptation of intestinal brush-border fructose transport in diabetes. Pflugers Arch 1996;432:192-201 (Pubitemid 26226101)
33. Reimer MK, Ahrén B. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice. Diabetes 2002;51(Suppl. 1):S138-S143 (Pubitemid 34761509)
34. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 2005;123:1307-1321 (Pubitemid 41821787)
35. Hou JC, Williams D, Vicogne J, Pessin JE. The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner. Endocrinology 2009;150:4056-4064
36. Bailey CJ, Wilcock C, Scarpello JH. Metformin and the intestine. Diabetologia 2008;51:1552-1553
37. Bailey CJ, Mynett KJ, Page T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol 1994;112:671-675 (Pubitemid 24172918)
38. Wilcock C, Bailey CJ. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 1994;24:49-57 (Pubitemid 24058005)
39. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-1174 (Pubitemid 32995375)
40. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444:1027-1031 (Pubitemid 46018515)
41. Eisenberg ML, Maker AV, Slezak LA, et al. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem 2005;15:51-58
42. Bady I, Marty N, Dallaporta M, et al. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding. Diabetes 2006;55: 988-995 (Pubitemid 44100173)
43. Stolarczyk E, Guissard C, Michau A, et al. Detection of extracellular glucose by GLUT2 contributes to hypothalamic control of food intake. Am J Physiol Endocrinol Metab 2010;298:E1078-E1087